Euroopa Liit - eesti - EMA (European Medicines Agency)

molmed spa - allogeense t rakke geneetiliselt muundatud retroviiruse vektori kodeering ma kärbitud kujul inimeste madal afiinsus närvi kasvufaktori retseptori (Δlngfr) ja herpes simplex viiruse tümidiinkinaasi (hsv-tk mut2 päriliku mutageensuse imetajate) - hematopoietic stem cell transplantation; graft vs host disease - antineoplastilised ained - zalmoxis on märgitud haploidentical vereloome tüvirakkude siirata vereloome ravina täiskasvanud patsientidel, kõrge riskiga.

Euroopa Liit - eesti - EMA (European Medicines Agency)

janssen-cilag international n.v. - darunavir, cobicistat - hiv-nakkused - antivirals for systemic use, antivirals for treatment of hiv infections, combinations - rezolsta on näidustatud koos teiste retroviirusevastaste ravimitega inimese immuunpuudulikkuse viiruse 1 (hiv 1) nakkuse raviks 18-aastastel ja vanematel täiskasvanutel. genotypic katsetamine peaks juhendi kasutamine rezolsta.

Euroopa Liit - eesti - EMA (European Medicines Agency)

intervet international b.v. - raku seotud live rekombinantse türgi herpesvirus (tüvi hvp360), väljendades fusion valk nd viiruse ja vp2 valgu kohta ibd viirus - lindude herpes viirus (marek tõbi) + lindude nakkav bursal haiguse viiruse (gumboro haigus) + newcastle ' i haiguse viiruse/paramyxovirus - chicken; embryonated chicken eggs - for active immunisation of one-day-old chicks or 18-19-day-old embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to prevent mortality and to reduce clinical signs and lesions caused by infectious bursal disease (ibd) virus,to reduce mortality, clinical signs and lesions caused by marek’s disease (md) virus.

Euroopa Liit - eesti - EMA (European Medicines Agency)

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - muud antineoplastilised ained - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.

Eesti - eesti - Ravimiamet

chanelle pharmaceuticals manufacturing limited - fiproniil - täpilahus - 402mg 4.02ml 4.02ml 3tk; 402mg 4.02ml 4.02ml 8tk; 402mg 4.02ml 4.02ml 2tk; 402mg 4.02ml 4.02ml 4tk; 402mg 4.02ml 4.02ml 6tk; 402mg 4.02ml 4.02ml 24tk; 402mg 4.02ml 4.02ml 15tk; 402mg 4.02ml 4.02ml 60tk; 402mg 4.02ml 4.02ml 9tk; 402mg 4.02ml 4.02ml 150tk; 402mg 4.02ml 4.02ml 12tk; 402mg 4.02ml 4.02ml 20tk; 402mg 4.02ml 4.02ml 1tk

Eesti - eesti - Ravimiamet

norbrook laboratories limited - fiproniil - täpilahus - 402mg 4.02ml 4.02ml 8tk; 402mg 4.02ml 4.02ml 4tk; 402mg 4.02ml 4.02ml 60tk; 402mg 4.02ml 4.02ml 3tk; 402mg 4.02ml 4.02ml 24tk; 402mg 4.02ml 4.02ml 90tk; 402mg 4.02ml 4.02ml 1tk; 402mg 4.02ml 4.02ml 30tk; 402mg 4.02ml 4.02ml 6tk

Eesti - eesti - Ravimiamet

bioveta a.s. - marutaudi inaktiveeritud viirusvaktsiin - süstesuspensioon - 10annus 10tk; 1annus 25tk; 20annus 5tk; 5annus 10tk; 1annus 50tk; 10annus 5tk

Eesti - eesti - Ravimiamet

norbrook laboratories (ireland) limited - fiproniil - täpilahus - 268mg 2.68ml 2.68ml 120tk; 268mg 2.68ml 2.68ml 60tk; 268mg 2.68ml 2.68ml 150tk; 268mg 2.68ml 2.68ml 90tk; 268mg 2.68ml 2.68ml 8tk; 268mg 2.68ml 2.68ml 24tk; 268mg 2.68ml 2.68ml 4tk; 268mg 2.68ml 2.68ml 6tk; 268mg 2.68ml 2.68ml 30tk; 268mg 2.68ml 2.68ml 12tk; 268mg 2.68ml 2.68ml 1tk; 268mg 2.68ml 2.68ml 2tk

Eesti - eesti - Ravimiamet

norbrook laboratories limited - fiproniil - täpilahus - 134mg 1.34ml 1.34ml 12tk; 134mg 1.34ml 1.34ml 4tk; 134mg 1.34ml 1.34ml 120tk; 134mg 1.34ml 1.34ml 90tk; 134mg 1.34ml 1.34ml 2tk; 134mg 1.34ml 1.34ml 1tk; 134mg 1.34ml 1.34ml 6tk; 134mg 1.34ml 1.34ml 150tk; 134mg 1.34ml 1.34ml 30tk

Eesti - eesti - Ravimiamet

teva gmbh - glatirameeratsetaat - süstelahus süstlis - 20mg 1ml 1ml 30tk; 20mg 1ml 1ml 7tk; 20mg 1ml 1ml 28tk; 20mg 1ml 1ml 90tk